ORMD-0801: Clinical Trials

3 trials of ORMD-0801, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 terminated, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Not yet recruiting 1, Terminated 1, Unknown 1

Follow ORMD-0801: new trials by email Literature Review of ORMD-0801 trials Research Report on ORMD-0801

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.
ORMD-0801 8 mg, Placebo capsule, ORMD-0801 16 mg - Type 2 Diabetes Mellitus
Phase 3Not yet recruitingOramed, Ltd.3002025-12-152025-08-03
Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
ORMD-0801 - Diabetes Mellitus, Type 2
Phase 3UnknownKing Hamad University Hospital, Bahrain6082021-10-012021-03-26
A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
ORMD-0801, Placebo - T2DM (Type 2 Diabetes Mellitus)
Phase 3TerminatedOramed, Ltd.3462021-03-162023-02-09

Conditions studied

Diabetes Mellitus, Type 2 (3)

Sponsors

Oramed, Ltd. (2)  ·  King Hamad University Hospital, Bahrain (1)

Countries

United States (2)

Top investigators

Dr. Dalal Alromaihi (1)  ·  Miriam Kidron, Ph.D. (1)  ·  Miriam Kidron, PhD (1)